Adhera Therapeutics Short Interest Ratio and Short Volume

Short interest is the volume of Adhera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 1,000 shares of ATRX short.

Adhera Therapeutics saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 1,000 shares, a decrease of 96.0% from the previous total of 25,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Adhera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Adhera Therapeutics: Earth Science Tech, Inc. (0.00%), ImmunoCellular Therapeutics, Ltd. (0.00%), Targeted Medical Pharma, Inc. (0.00%), W World Corp. (0.00%), Aoxing Pharmaceutical Company, Inc. (0.00%), Anthera Pharmaceuticals, Inc. (0.00%), Achaogen, Inc. (0.00%), Aeolus Pharmaceuticals, Inc. (0.00%), Propanc Biopharma, Inc. (0.00%), and Praxsyn Co. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($9.74 billion), Aon plc ($5.63 billion), Charter Communications, Inc. ($5.41 billion), Analog Devices, Inc. ($5.32 billion), Baidu, Inc. ($4.45 billion), Snap Inc. ($3.86 billion), Discovery, Inc. ($3.30 billion), Airbnb, Inc. ($2.82 billion), GameStop Corp. ($2.70 billion), and Bilibili Inc. ($2.34 billion). View all of the most shorted stocks.

Short selling ATRX is an investing strategy that aims to generate trading profit from Adhera Therapeutics as its price is falling. Adhera Therapeutics' stock is trading up $0.00 today. To short Adhera Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Adhera Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Adhera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRX, twice per month. The most recent reporting period available is March, 15 2021.